Category

Bayer’s plan for settling future Roundup cancer claims faces broad opposition

Posted on by Carey Gillam

Dozens of U.S. law firms have formed a coalition to fight a new $2 billion settlement proposal by Monsanto owner Bayer AG that aims to contain the company’s ongoing liability related to claims that Roundup herbicides cause a type of cancer known as non-Hodgkin lymphoma (NHL). The settlement is designed to compensate people who have … Continue reading “Bayer’s plan for settling future Roundup cancer claims faces broad opposition”

EPA’s assessments of chemicals draws criticism from its own scientists

Posted on by Carey Gillam

Many U.S. scientists working for the Environmental Protection Agency (EPA) say they don’t trust the agency’s senior leaders to be honest and they fear retaliation if they were to report a violation of the law, according to a survey of employees conducted in 2020. According to the Federal Employee Viewpoint Survey for 2020, which was … Continue reading “EPA’s assessments of chemicals draws criticism from its own scientists”

Another Roundup study finds links to potential human health problems

Posted on by Carey Gillam

A new scientific paper examining the potential health impacts of Roundup herbicides found links between exposure to the weed killing chemical glyphosate and an increase in a type of amino acid known to be a risk factor for cardiovascular disease. The researchers made their determinations after exposing pregnant rats and their newborn pups to glyphosate … Continue reading “Another Roundup study finds links to potential human health problems”

Emails show scientists discussed masking their involvement in key journal letter on Covid origins

Posted on by Carey Gillam

EcoHealth Alliance President Peter Daszak, the head of an organization involved in research that genetically manipulates coronaviruses, discussed hiding his role in a statement published last year in The Lancet that condemned as “conspiracy theories” concerns that the COVID-19 virus may have originated in a research lab, emails obtained by US Right to Know show. The Lancet … Continue reading “Emails show scientists discussed masking their involvement in key journal letter on Covid origins”

Litigation Update: Bayer Announces a $2B Deal to Resolve Future Roundup Cancer Claims

Posted on by Edward Lott

On Friday, February 3, 2021, Bayer AG announced that it had reached a formal agreement with plaintiffs’ class counsel to resolve future Roundup claims. As part of the agreement currently awaiting approval before presiding Judge Vince Chhabria of the U.S. District Court for the Northern District of California, Bayer has committed to paying up to … Continue reading “Litigation Update: Bayer Announces a $2B Deal to Resolve Future Roundup Cancer Claims”

Litigation Update: Valsartan Manufacturers to Face Fraud Claims

Posted on by Edward Lott

On January 29, the judge presiding over the Valsartan litigation, US District Judge Robert B. Kugler refused to dismiss claims of fraud brought by the consumers against the defendant manufacturers in three master complaints; similar claims against wholesalers and pharmacies, however, will be thrown out without prejudice. In an effort to dismiss the claims that … Continue reading “Litigation Update: Valsartan Manufacturers to Face Fraud Claims”

Bayer makes new $2 billion plan to head off future Roundup cancer claims

Posted on by Carey Gillam

Monsanto owner Bayer AG said Wednesday it was attempting again to manage and resolve potential future Roundup cancer claims, laying out a $2 billion deal with a group of plaintiffs’ attorneys that Bayer hopes will win approval from a federal judge who rejected a prior plan last summer. Notably, the deal calls for Bayer to … Continue reading “Bayer makes new $2 billion plan to head off future Roundup cancer claims”

Mass Tort and Class Action Outlook for 2021

Posted on by Edward Lott

As we move into 2021, it is helpful to assess the current state of mass torts and class action and think about how these matters may develop over the course of the year. Despite the impact of the COVID pandemic, some matters are picking up momentum, some long-standing cases are heading toward settlement and new … Continue reading “Mass Tort and Class Action Outlook for 2021”

ForLawFirmsOnly Marketing, Inc. © 1994-2021 All Rights Reserved